{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:30:33Z","timestamp":1782390633558,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuro.2025.103379","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:10:40Z","timestamp":1767208240000},"page":"103379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibitory effects of (synthetic) cannabinoids and (designer) benzodiazepines on spontaneously active neuronal networks of primary rat cortical cultures in vitro"],"prefix":"10.1016","volume":"112","author":[{"given":"J. Pepijn","family":"Wopken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G.D.M.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-2007","authenticated-orcid":false,"given":"Remco H.S.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2025.103379_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109481","article-title":"Ketamine reduces electrophysiological network activity in cortical neuron cultures already at sub-micromolar concentrations - impact on TrkB-ERK1\/2 signaling","volume":"229","author":"Ahtiainen","year":"2023","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuro.2025.103379_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186147","article-title":"Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings","volume":"12","author":"Bader","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2025.103379_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA(A) receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuro.2025.103379_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11419-015-0282-9","article-title":"Structure\u2013activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues","volume":"33","author":"Banister","year":"2015","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2025.103379_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cptx.67","article-title":"Screening for neurotoxicity with microelectrode array","volume":"79","author":"Bradley","year":"2019","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","article-title":"Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017","volume":"57","author":"Carpenter","year":"2019","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5487\/TR.2019.35.1.037","article-title":"Receptor binding affinities of synthetic cannabinoids determined by non-isotopic receptor binding assay","volume":"35","author":"Cha","year":"2019","journal-title":"Toxicol. Res"},{"key":"10.1016\/j.neuro.2025.103379_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.01.043","article-title":"Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons","volume":"823","author":"Costain","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neuro.2025.103379_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/1087057116640520","article-title":"Characterization of early cortical neural network development in multiwell microelectrode array plates","volume":"21","author":"Cotterill","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.neuro.2025.103379_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03602532.2017.1377223","article-title":"Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.neuro.2025.103379_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109244","article-title":"Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020","volume":"231","author":"Essink","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuro.2025.103379_bib12","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2013) Benzodiazepines drug profile. Available at: \u3008https:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/benzodiazepines_en\u3009 (Accessed: 21 November 2023)."},{"key":"10.1016\/j.neuro.2025.103379_bib13","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2020) European drug report 2020: trends and developments. Available at: \u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13236\/TDAT20001ENN_web.pdf\u3009 (Accessed: 21 November 2023)."},{"key":"10.1016\/j.neuro.2025.103379_bib14","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2023) European Drug Report 2023: Trends and Developments. Available at: \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en\u3009 (Accessed: 21 November 2023)."},{"key":"10.1016\/j.neuro.2025.103379_bib15","unstructured":"European Union Drugs Agency (2024) Source data for EU Drug Market: EU Drug Market: New psychoactive substances \u2014 In-depth analysis. Available at: \u3008https:\/\/www.euda.europa.eu\/data\/repository\/source-data-eu-drug-market-eu-drug-market-new-psychoactive-substances-%E2%80%94-depth-analysis_en#edmr24-nps-fig5-nps-reported-to-ews-2005-2023\u3009 (accessed: 14 December 2025)."},{"key":"10.1016\/j.neuro.2025.103379_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ADM.0000000000000884","article-title":"Evidence of designer benzodiazepine use in routine healthcare urine drug specimens","volume":"16","author":"Garland","year":"2022","journal-title":"J. Addict. Med"},{"issue":"6","key":"10.1016\/j.neuro.2025.103379_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.158","article-title":"Culture of rat primary cortical cells for microelectrode array (MEA) recordings to screen for acute and developmental neurotoxicity","volume":"1","author":"Gerber","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuro.2025.103379_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfs269","article-title":"Don\u2019t judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing","volume":"132","author":"de Groot","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2025.103379_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13041-015-0099-9","article-title":"Ontogeny of biochemical, morphological and functional parameters of synaptogenesis in primary cultures of rat hippocampal and cortical neurons","volume":"8","author":"Harrill","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuro.2025.103379_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1989.101","article-title":"Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect","volume":"46","author":"Herman","year":"1989","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.neuro.2025.103379_bib21","series-title":"Patch Clamp Electrophysiology: Methods and Protocols","first-page":"1","article-title":"An introduction to patch clamp recording","author":"Hill","year":"2021"},{"key":"10.1016\/j.neuro.2025.103379_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2016.04.020","article-title":"Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings","volume":"55","author":"Hondebrink","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2025.103379_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(01)03117-1","article-title":"Functional analysis of GABA(A) receptors in nucleus tractus solitarius neurons from neonatal rats","volume":"921","author":"Huang","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2025.103379_bib24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1152\/jn.2002.88.4.1655","article-title":"Functional characterization of GABA(A) receptors in neonatal hypothalamic brain slice","volume":"88","author":"Huang","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuro.2025.103379_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuro.2010.04.001","article-title":"Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century","volume":"31","author":"Johnstone","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2025.103379_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jvc.2007.02.001","article-title":"The patch clamp technique: principles and technical considerations","volume":"9","author":"Kornreich","year":"2007","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.neuro.2025.103379_bib27","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuro.2025.103379_bib28","doi-asserted-by":"crossref","DOI":"10.1152\/jn.1985.53.4.926","article-title":"Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons","volume":"53","author":"Legendy","year":"1985","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuro.2025.103379_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review","volume":"41","author":"Logan","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","article-title":"Designer drugs: mechanism of action and adverse effects","volume":"94","author":"Luethi","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40263-024-01098-9","article-title":"The state of synthetic cannabinoid medications for the treatment of pain","volume":"38","author":"Maglaviceanu","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuro.2025.103379_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.forsciint.2018.08.009","article-title":"Cannabinoid concentrations in blood and urine after smoking cannabidiol joints","volume":"291","author":"Meier","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2025.103379_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuro.2024.04.004","article-title":"Effects of acute insecticide exposure on neuronal activity in vitro in rat cortical cultures","volume":"102","author":"van Melis","year":"2024","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.neuro.2025.103379_bib34","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A Systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuro.2025.103379_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.irn.2024.03.009","article-title":"Cannabidiol and epilepsy","volume":"177","author":"Moreira","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuro.2025.103379_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1469-7793.2001.00453.x","article-title":"Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy","volume":"537","author":"Mtchedlishvili","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuro.2025.103379_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.irn.2024.04.016","article-title":"Cannabidiol and pain","volume":"177","author":"Nascimento","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuro.2025.103379_bib38","unstructured":"NVIC (2023), Nationaal Vergiftigingen Informatie Centrum, NVIC Jaaroverzicht 2022 - Rapport 01\/2023. Available at: \u3008https:\/\/assets-eu-01.kc-usercontent.com\/4ecb7ebb-946a-0154-473e-737dbc98bace\/75b8bf34-c949-4017-8790-1659e17ca3c0\/NVIC-jaaroverzicht%202022.pdf\u3009 (Accessed: 21 July 2024)."},{"key":"10.1016\/j.neuro.2025.103379_bib39","unstructured":"Office for National Statistics. Drugs misuse: findings from the 2018\/19 crime survey for England and Wales. London (UK): Home Office Statistical Bulletin; 2019. Available at \u3008https:\/\/www.gov.uk\/government\/statistics\/drug-misuse-findings-from-the-2018-to-2019-csew\u3009 (Accessed: 21 July 2024)."},{"key":"10.1016\/j.neuro.2025.103379_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1570159X18666200110121333","article-title":"New\/Designer benzodiazepines: an analysis of the literature and psychonauts\u2019 trip reports","volume":"18","author":"Orsolini","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuro.2025.103379_bib41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1515\/cclm-2019-0119","article-title":"THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of \"light cannabis\"","volume":"58","author":"Pacifici","year":"2020","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.neuro.2025.103379_bib42","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1111\/bph.14829","article-title":"In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors","volume":"176","author":"Sachdev","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuro.2025.103379_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tiv.2015.05.016","article-title":"Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models","volume":"30","author":"Schultz","year":"2015","journal-title":"Toxicol. Vitr."},{"issue":"4","key":"10.1016\/j.neuro.2025.103379_bib44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2125.2008.03252.x","article-title":"The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam","volume":"66","author":"Smink","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuro.2025.103379_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00204-017-2035-5","article-title":"Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA)","volume":"92","author":"Strickland","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib46","doi-asserted-by":"crossref","first-page":"i6848","DOI":"10.1136\/bmj.i6848","article-title":"Novel psychoactive substances: types, mechanisms of action, and effects","volume":"356","author":"Tracy","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.neuro.2025.103379_bib47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/17425255.2021.1876026","article-title":"Novel test strategies for in vitro seizure liability assessment","volume":"17","author":"Tukker","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib48","unstructured":"United Nations Office of Drugs and Crime (2023) World drug report 2023. Vienna (Austria): United Nations Publication; 2023. Available at \u3008https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html\u3009 (Accessed: 17 July 2024)."},{"issue":"4","key":"10.1016\/j.neuro.2025.103379_bib49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1157.1984.tb03444.x","article-title":"Lorazepam: a controlled trial in patients with intractable partial complex seizures","volume":"25","author":"Walker","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuro.2025.103379_bib50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15563650.2024.2346125","article-title":"Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020","volume":"62","author":"Waters","year":"2024","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuro.2025.103379_bib51","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.3390\/molecules27154961","article-title":"Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders","volume":"27","author":"Yousaf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuro.2025.103379_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17512433.2023.2170349","article-title":"Designer benzodiazepines: an update","volume":"16","author":"Yu","year":"2023","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neuro.2025.103379_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances-designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.neuro.2025.103379_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-070815-014038","article-title":"Beyond the CB1 receptor: is cannabidiol the answer for disorders of motivation?","volume":"39","author":"Zlebnik","year":"2016","journal-title":"Annu. Rev. Neurosci."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25001858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25001858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:23:59Z","timestamp":1770931439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X25001858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"alternative-id":["S0161813X25001858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2025.103379","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of (synthetic) cannabinoids and (designer) benzodiazepines on spontaneously active neuronal networks of primary rat cortical cultures in vitro","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2025.103379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103379"}}